1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Biobanks Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Biobanks Market – Key Market Dynamics
5.4 Impact of Drivers and Restraints
6. Europe Biobanks Market Regional Analysis
6.1 Europe Biobanks Market Overview
6.2 Europe Biobanks Market Revenue 2019-2028 (US$ Million)
6.3 Europe Biobanks Market Forecast Analysis
7. Europe Biobanks Market Analysis – by Product and Service
7.1 Equipment
- 7.1.1 Overview
- 7.1.2 Equipment: Europe Biobanks Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Consumables
- 7.2.1 Overview
- 7.2.2 Consumables: Europe Biobanks Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Service
- 7.3.1 Overview
- 7.3.2 Service: Europe Biobanks Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Software
- 7.4.1 Overview
- 7.4.2 Software: Europe Biobanks Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Biobanks Market Analysis – by Sample
8.1 Blood Products
- 8.1.1 Overview
- 8.1.2 Blood Products: Europe Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Human Tissues
- 8.2.1 Overview
- 8.2.2 Human Tissues: Europe Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Cell Lines
- 8.3.1 Overview
- 8.3.2 Cell Lines: Europe Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Biobanks Market Analysis – by Application
9.1 Regenerative Medicine
- 9.1.1 Overview
- 9.1.2 Cell Lines: Europe Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Life Science Research
- 9.2.1 Overview
- 9.2.2 Cell Lines: Europe Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Clinical Research
- 9.3.1 Overview
- 9.3.2 Cell Lines: Europe Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe Biobanks Market – Europe Analysis
10.1 Europe
- 10.1.1 Europe Biobanks Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.1.1.1 Europe Biobanks Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 UK:
Europe Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 UK: Europe Biobanks Market Breakdown, by Product and Service
- 10.1.1.1.2 UK: Europe Biobanks Market Breakdown, by Sample
- 10.1.1.1.3 UK: Europe Biobanks Market Breakdown, by Application
- 10.1.1.2 Germany:
Europe Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Germany: Europe Biobanks Market Breakdown, by Product and Service
- 10.1.1.2.2 Germany: Europe Biobanks Market Breakdown, by Sample
- 10.1.1.2.3 Germany: Europe Biobanks Market Breakdown, by Application
- 10.1.1.3 France:
Europe Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 France: Europe Biobanks Market Breakdown, by Product and Service
- 10.1.1.3.2 France: Europe Biobanks Market Breakdown, by Sample
- 10.1.1.3.3 France: Europe Biobanks Market Breakdown, by Application
- 10.1.1.4 Russia:
Europe Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.4.1 Russia: Europe Biobanks Market Breakdown, by Product and Service
- 10.1.1.4.2 Russia: Europe Biobanks Market Breakdown, by Sample
- 10.1.1.4.3 Russia: Europe Biobanks Market Breakdown, by Application
- 10.1.1.5 Italy:
Europe Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.5.1 Italy: Europe Biobanks Market Breakdown, by Product and Service
- 10.1.1.5.2 Italy: Europe Biobanks Market Breakdown, by Sample
- 10.1.1.5.3 Italy: Europe Biobanks Market Breakdown, by Application
- 10.1.1.6 Rest of Europe:
Europe Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.6.1 Rest of Europe: Europe Biobanks Market Breakdown, by Product and Service
- 10.1.1.6.2 Rest of Europe: Europe Biobanks Market Breakdown, by Sample
- 10.1.1.6.3 Rest of Europe: Europe Biobanks Market Breakdown, by Application
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Europe Biobanks Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Tecan Trading AG
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 QIAGEN
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Hamilton Company
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Avantor, Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 MICRONICS JAPAN CO., LTD.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 BD
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Taylor-Wharton
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Brooks Automation, Inc.
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Promega Corporation
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 SciSafe Inc.
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
13.12 Biovault Family
- 13.12.1 Key Facts
- 13.12.2 Business Description
- 13.12.3 Products and Services
- 13.12.4 Financial Overview
- 13.12.5 SWOT Analysis
- 13.12.6 Key Developments
14. Appendix
14.1 About Business Market Insights